Details for Patent: 6,066,339
✉ Email this page to a colleague
Summary for Patent: 6,066,339
Title: | Oral morphine multiparticulate formulation |
Abstract: | An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polymer coat comprised of ammonio methacrylate copolymers in an amount sufficient to achieve therapeutically effective plasma levels of morphine over at least 24 hours in the patient. |
Inventor(s): | Stark; Paul (Althone, IE), Cunningham; Sean (Althone, IE), Moodley; Jagathesan (Althone, IE) |
Assignee: | Elan Corporation, plc (Dublin, IE) |
Application Number: | 08/977,965 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,066,339 |
Patent Claim Types: see list of patent claims | Formulation; |
Drugs Protected by US Patent 6,066,339
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,066,339
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 239454 | ⤷ Sign Up | |||
Australia | 5408098 | ⤷ Sign Up | |||
Canada | 2306333 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |